Literature DB >> 28492536

Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.

Emma Healey1,2, Natalie Taylor3, Sian Greening2, Claire E Wakefield4,5, Linda Warwick6, Rachel Williams1,7, Kathy Tucker7.   

Abstract

PurposeRecommendations for BRCA1 and BRCA2 mutation carriers to disseminate information to at-risk relatives pose significant challenges. This study aimed to quantify family dissemination, to explain the differences between fully informed families (all relatives informed verbally or in writing) and partially informed families (at least one relative uninformed), and to identify dissemination barriers.MethodsBRCA1 and BRCA2 mutation carriers identified from four Australian hospitals (n=671) were invited to participate in the study. Distress was measured at consent using the Kessler psychological distress scale (K10). A structured telephone interview was used to assess the informed status of relatives, geographical location of relatives, and dissemination barriers. Family dissemination was quantified, and fully versus partially informed family differences were examined. Dissemination barriers were thematically coded and counted.ResultsA total of 165 families participated. Information had been disseminated to 81.1% of relatives. At least one relative had not been informed in 52.7% of families, 4.3% were first-degree relatives, 27.0% were second-degree relatives, and 62.0% were cousins. Partially informed families were significantly larger than fully informed families, had fewer relatives living in close proximity, and exhibited higher levels of distress. The most commonly recorded barrier to dissemination was loss of contact.ConclusionLarger, geographically diverse families have greater difficulty disseminating BRCA mutation risk information to all relatives. Understanding these challenges can inform future initiatives for communication, follow-up and support.

Entities:  

Mesh:

Year:  2017        PMID: 28492536     DOI: 10.1038/gim.2017.52

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  36 in total

Review 1.  Communicating genetic risk information within families: a review.

Authors:  Mel Wiseman; Caroline Dancyger; Susan Michie
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 2.  Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information.

Authors:  Gillian Nycum; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2009-03-25       Impact factor: 4.246

3.  Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

Authors:  Erna Claes; Gerry Evers-Kiebooms; Andrea Boogaerts; Marleen Decruyenaere; Lieve Denayer; Eric Legius
Journal:  Am J Med Genet A       Date:  2003-01-01       Impact factor: 2.802

Review 4.  Communication and technology in genetic counseling for familial cancer.

Authors:  H T Lynch; C Snyder; M Stacey; B Olson; S K Peterson; S Buxbaum; T Shaw; P M Lynch
Journal:  Clin Genet       Date:  2013-12-20       Impact factor: 4.438

5.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

6.  A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

Authors:  David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman
Journal:  Health Psychol       Date:  2002-11       Impact factor: 4.267

7.  Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations.

Authors:  Esme Finlay; Jill E Stopfer; Eric Burlingame; Katherine Goldfeder Evans; Katherine L Nathanson; Barbara L Weber; Katrina Armstrong; Timothy R Rebbeck; Susan M Domchek
Journal:  Genet Test       Date:  2008-03

8.  Germline BRCA1 mutations increase prostate cancer risk.

Authors:  D Leongamornlert; N Mahmud; M Tymrakiewicz; E Saunders; T Dadaev; E Castro; C Goh; K Govindasami; M Guy; L O'Brien; E Sawyer; A Hall; R Wilkinson; D Easton; D Goldgar; R Eeles; Z Kote-Jarai
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640

9.  BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.

Authors:  Z Kote-Jarai; D Leongamornlert; E Saunders; M Tymrakiewicz; E Castro; N Mahmud; M Guy; S Edwards; L O'Brien; E Sawyer; A Hall; R Wilkinson; T Dadaev; C Goh; D Easton; D Goldgar; R Eeles
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

10.  Increased genetic counseling support improves communication of genetic information in families.

Authors:  Laura E Forrest; Jo Burke; Sonya Bacic; David J Amor
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  13 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

Review 2.  Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review.

Authors:  Alison L Young; Phyllis N Butow; Janine Vetsch; Veronica F Quinn; Andrea F Patenaude; Katherine M Tucker; Claire E Wakefield
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

Review 3.  Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.

Authors:  Alison Luk Young; Aalya Imran; Michael J Spoelma; Rachel Williams; Katherine M Tucker; Jane Halliday; Laura E Forrest; Claire E Wakefield; Phyllis N Butow
Journal:  Eur J Hum Genet       Date:  2022-10-17       Impact factor: 5.351

4.  Aligning intuition and theory: enhancing the replicability of behaviour change interventions in cancer genetics.

Authors:  Natalie Taylor; Emma Healey; April Morrow; Sian Greening; Claire E Wakefield; Linda Warwick; Rachel Williams; Katherine M Tucker
Journal:  Implement Sci Commun       Date:  2020-10-14

5.  Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.

Authors:  Marleah Dean; Ann L Tezak; Sabrina Johnson; Joy K Pierce; Anne Weidner; Kate Clouse; Tuya Pal; Deborah Cragun
Journal:  Patient Educ Couns       Date:  2021-01-05

6.  Examining the uptake of predictive BRCA testing in the UK; findings and implications.

Authors:  Karen Lynn Greenhalgh; Munir Pirmohamed; Antony P Martin; Jennifer Downing; Brendan Collins; Brian Godman; Ana Alfirevic
Journal:  Eur J Hum Genet       Date:  2020-12-16       Impact factor: 4.246

7.  When to break the news and whose responsibility is it? A cross-sectional qualitative study of health professionals' views regarding disclosure of BRCA genetic cancer risk.

Authors:  Alison Luk Young; Phyllis N Butow; Katherine M Tucker; Claire E Wakefield; Emma Healey; Rachel Williams
Journal:  BMJ Open       Date:  2020-02-25       Impact factor: 2.692

8.  Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design.

Authors:  Chiara L Blomen; Aliaksandra Pott; Alexander E Volk; Lars Budäus; Isabell Witzel
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

9.  Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment.

Authors:  Bradley A Rolf; Jennifer L Schneider; Laura M Amendola; James V Davis; Kathleen F Mittendorf; Mark A Schmidt; Gail P Jarvik; Benjamin S Wilfond; Katrina A B Goddard; Jessica Ezzell Hunter
Journal:  J Genet Couns       Date:  2021-07-23       Impact factor: 2.537

10.  Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience.

Authors:  Jianbang Chiang; Jeanette Yuen; Tarryn Shaw; Hui Xuan Goh; Shao-Tzu Li; Eliza Courtney; Joanne Ngeow
Journal:  Front Pediatr       Date:  2020-10-30       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.